BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1661 related articles for article (PubMed ID: 18374761)

  • 1. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
    Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
    Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
    Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
    J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
    Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
    Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
    Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
    N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.
    Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H
    J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT, positron emission tomography, and MRI in staging lung cancer.
    Erasmus JJ; Sabloff BS
    Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging lung cancer.
    Patz EF
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):21-6. PubMed ID: 10566607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
    Cerfolio RJ; Bryant AS; Ojha B
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography.
    Kiernan PD; Sheridan MJ; Lamberti J; Dicicco B; Wigton R; Hetrick V; Vaughan B; Graling P
    South Med J; 2002 Oct; 95(10):1168-72. PubMed ID: 12425503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
    Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K
    Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer.
    Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R
    Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1087-92. PubMed ID: 15052206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging.
    Koşucu P; Tekinbaş C; Erol M; Sari A; Kavgaci H; Oztuna F; Ersöz S
    J Magn Reson Imaging; 2009 Aug; 30(2):292-7. PubMed ID: 19629990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
    Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
    Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
    Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
    Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.